Dr. Marcus Schabacker became president and chief executive officer of ECRI Institute in January 2018*. Dr. Schabacker is a board-certified anesthesiologist and intensive care specialist with more than 25 years of healthcare experience in complex global environments, and more than 18 years of senior leadership responsibilities serving the medical device and pharmaceutical industries across the healthcare value chain.
After completing clinical and academic practice in Germany and South Africa, Dr. Schabacker leveraged deep clinical, regulatory, and operational expertise to enhance scientific, technical, medical, and regulatory capabilities at companies such as Baxter and Bristol-Myers Squibb. His experience includes designing, transforming, and leading organizations of up to 4,000 employees across five continents to provide safe and effective products to patients and healthcare providers worldwide.
During his clinical years, and his time as an industry thought leader, Dr. Schabacker has been focused on patient safety and enhancing patient care.
As part of his early career, Schabacker served as senior medical officer and head of the intensive care and anesthesia department at the Mafikeng General Hospital, North-West Province, South Africa. His work there was part of a humanitarian aid program to support the African National Congress government under Nelson Mandela in the restructuring and buildup of a rural healthcare system in post-apartheid South Africa.
After his return from Africa, Dr. Schabacker joined the medical device industry and held roles of increasing responsibility in medical affairs, preclinical and clinical development, regulatory affairs, quality, research and development, and patient safety. In his last corporate role prior to joining ECRI Institute, Dr. Schabacker served as corporate vice president and chief scientific officer at Baxter.
Dr. Schabacker achieved his board certification in anesthesia and intensive care, as well as a doctorate in medicine from the Medical University, Lubeck, Germany. He also received certifications in emergency medicine and disaster medicine.
Per the request of ECRI Institute’s Board of Trustees, Dr. Schabacker agrees to recuse himself from decision-making on matters related to Baxter for a period of one year. This recusal process helps to avoid any actual, potential or perceived conflicts of interest and, thus, safeguard ECRI Institute’s reputation for independence and impartiality.